Androgen receptor signalling confers clonogenic and migratory advantages in urothelial cell carcinoma of the bladder-Reference-Cited by-同舟云学术

Androgen receptor signalling confers clonogenic and migratory advantages in urothelial cell carcinoma of the bladder

Published:2021-05-22 Issue: Volume: Page:
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Luna‐Velez Maria V.¹²^ORCID,Dijkstra Jelmer J.²,Heuschkel Marina A.¹,Smit Frank P.³,van de Zande Guillaume⁴,Smeets Dominique⁴,Sedelaar J. P. Michiel¹,Vermeulen Michiel²,Verhaegh Gerald W.¹,Schalken Jack A.¹

Affiliation:

1. Department of Urology Radboud Institute for Molecular Life Sciences Radboud University Medical Center Nijmegen the Netherlands

2. Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute Radboud University Nijmegen the Netherlands

3. MDxHealth Nijmegen the Netherlands

4. Department of Genetics Radboud Institute for Molecular Life Sciences Radboud University Medical Center Nijmegen the Netherlands

Funder

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12957

Reference78 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray F;CA Cancer J Clin,2018